Clinical Trial Update: Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed with or without PF-3512676 in advanced non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PF-3512676
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Non-Small Cell Lung | Phase 2 | Status: TERMINATED